The primary purpose of this study is to compare the short (12 week) and long-term (1-year)
efficacy and the tolerability between stepwise psychopharmacotherapy and antidepressant
monotherapy for 12 weeks in adult patients with major depressive disorders, stratified by the
multimodal serum biomarker scores.